| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Sio Gene Therapies (NASDAQ:SIOX) reported its Q1 earnings results on Thursday, August 11, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Sio Gene Therapies beat estimated earnings by 42.11%, reporting an EPS of $-0.11 versus an estimate of $-0.19.
Revenue was down $0 from the same period last year.
Last quarter the company beat on EPS by $0.02 which was followed by a 1.41% increase in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for Sio Gene Therapies visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: SIOX
